[Federal Register Volume 59, Number 144 (Thursday, July 28, 1994)]
[Unknown Section]
[Page ]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-18389]


[Federal Register: July 28, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[GN # 2260]


Statement of Organization, Functions, and Delegations of 
Authority

    Part H, Chapter HF (Food and Drug Administration) of the Statement 
of Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (35 FR 3685, February 25, 1970, 
and 56 FR 29484, June 27, 1991, as amended most recently in pertinent 
part at 58 FR 45111, August 26, 1993) is amended to reflect the 
establishment of the Office of Women's Health in the Office of External 
Affairs, Food and Drug Administration (FDA). The organization is being 
established to facilitate the Agency coordination and communication of 
women's health issues and initiatives.
    Under Section HF-B, Organization:
    1. Insert a new subparagraph under Office of External Affairs 
(HFAQ) reading as follows:
    Office of Women's Health. Serves as the principal advisor to the 
Commissioner and other key officials on scientific, ethical, and policy 
issues relating to women's health.
    Provides leadership and policy direction for the Agency regarding 
issues of women's health and coordinates efforts to establish and 
advance a women's health agenda for the Agency.
    Monitors the inclusion of women in clinical trials and the 
implementation of guidelines concerning the representation of women in 
clinical trials and the completion of gender analysis.
    Identifies and monitors the progress of crosscutting and 
multidisciplinary women's health initiatives including changing needs, 
areas that require study, and new challenges to the health of women as 
they relate to FDA's mission.
    Serves as the Agency's liaison with other agencies, industry, and 
professional associations with regard to the health of women.

    Dated: July 11, 1994.
David A. Kessler,
Commissioner of Food and Drugs.
[FR Doc. 94-18389 Filed 7-27-94; 8:45 am]
BILLING CODE 4160-01-M